CHICAGO--(BUSINESS WIRE)--Sensydia, a clinical-stage non-invasive cardiac assessment company, announced today that University of Minnesota investigators presented positive clinical findings from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results